Full Focus: Generate Revenue & Serve Patients by Implementing a Direct-to-Consumer Offering
With medical labs continuing to feel a financial squeeze after years of reimbursement cuts to core services, many are beginning to explore new avenues for generating revenue. One pathway to bolstering your bottom line that's gaining traction is adding direct-to-consumer (DTC) ordering of your lab's test menu.
Join us at 1 p.m. EDT, Oct. 25, 2023, as we welcome John Constantine and Bob Mann of ARCpoint Labs to provide an overview of the current state of the DTC testing market and projected growth in the near future. They will also cover the components a lab should have in place to perform DTC testing and offer a playbook for how labs can pursue this strategy on their own.
|
|
1. CMS Approves New Certification for High-Complexity Lab Directors
On July 24, 2023, CMS sent out a memorandum to all State Survey Agency Directors with the approval of a new board certification for high-complexity laboratory directors.
|
|
|
2. Introducing: The Lighthouse Candidate Corner
As our Recruiting Team continues to place great candidates in labs across the country each week, we're starting a new initiative to highlight some of our most-placeable candidates. With that in mind, we're introducing the "Candidate Corner" where we'll feature multiple blind profiles each month.
Check out a quick preview below and click over to our blog to see all candidates for October. If you'd like to learn more about anyone listed in this section, email us directly here!
Candidate - MLT Supervisor
-
Education: A.S. in MLT, B.S. in MLS in process
-
Certifications: MLT (ASCP)
-
Experience/Expertise: Generalist, Blood Bank, PCR, LCMS
|
|
|
3. FDA Proposes Added Oversight for LDTs Under New Rule
The FDA recently released its long-anticipated proposal to formally place laboratory-developed tests (LDTs) under the agency's oversight. Under the new rules, the FDA would phase out its general enforcement discretion approach for most LDTs and generally would require labs and IVD developers to meet the same requirements before offering a new test.
While the proposal is under a 60-day comment period until Dec. 4 (with a possible extension forthcoming), we recently polled our LinkedIn audience about whether they currently support this change. Out of 423 respondents, 63% indicated they do not currently support the proposal, while 22% said they need more information.
|
|
|
4. Is Your Lab Prepared for Flu, RSV, & COVID this winter?
As medical labs ramp up to assist in the fight against seasonal viruses this winter, we want to provide a reminder that Lighthouse Lab Services can help your lab add testing for Flu, RSV, and COVID.
We can add Influenza A/B and/or Respiratory Syncytial Virus (RSV) A/B testing to existing COVID testing platforms or as a standalone service. Additionally, our CovidNow and SalivaNow assay kits are available for labs seeking a SARS-CoV-2 RT-PCR testing solution.
If your lab needs accurate, reliable assays, reach out to us today. We will ensure you are equipped to meet your community’s testing needs.
|
|
1. Leveraging AI to Improve Payer Contracting
Effectively communicating with payers can be difficult, especially when there's a dispute between you and the insurer that could substantially impact your revenue. In addition to expert guidance, did you know there are AI tools available to help you craft effective replies to payer inquiries?
In our latest case study, our RCM Solutions Team details how they used AI to help identify and resolve a payer error after our client received takeback demands dating back years and totaling tens of thousands of dollars.
|
|
|
2. Pushing Back Against Proposed Medicare Fee Schedule Cuts
Don't forget, now is the time to speak out against proposed Medicare fee schedule cuts that will further reduce overall reimbursements for pathologists and independent labs by roughly 2% in 2024!
The College of American Pathologists (CAP) is currently leading an effort to halt the introduction of a new evaluation and management add-on service (G2211), which they say will result in inappropriate overpayments for those using it at the expense of specialists such as pathologists. Check out the link below for more information and to learn how you can speak out against these reductions!
|
|
Deep Dive: Upcoming FREE Educational Urine Drug Testing Webinar Series (Earn Continuing Education Credits) |
|
Beginning this month, Lighthouse is partnering with the Pain Society of the Carolinas, New York Pain Society, Tennessee Pain Society, and Pennsylvania Pain Society, to conduct a series of free educational webinars on drug testing. Attendees can earn up to 1 ACCME AMA PRA Category 1 Credit for their participation, with credits jointly provided by AMEDCO. Check out the full lineup below and be sure to sign up soon using the title links below!
Topic #1: Urine Drug Testing 101 - Produced in conjunction with the Rothman Othopaedic Institute Foundation for Opioid Research
Presented by: Michael Sprintz, DO, and Elliot Labovitz, Lighthouse Lab Services
Date: Thursday, Oct. 26, 2023, 7-8 PM Eastern
Presented by: Dr. Erik Korte, Lab Director & TC, Lighthouse Lab Services
Date: Wednesday, Nov. 1, 2023, 7-8 PM Eastern
Presented by: Dr. Sarah Harris, Chief Technical Officer, Lighthouse Lab Services
Date: Wednesday, Nov. 15, 2023, 7-8 PM Eastern
Faculty: Ann Lambrix, MSJ, VP of RCM Consulting, Lighthouse Lab Services
Date: Wednesday, Dec. 13, 2023, 7-8 PM Eastern
|
|
UPCOMING TRADESHOWS AND CONFERENCES |
|
|
This email is brought to you as a service from Lighthouse Lab Services to provide quality and timely information that can improve your laboratory operations. We strive to maintain our position as the country’s premiere lab consulting firm and support your success. |
|
The Lab Insighter is a monthly publication for Lab Owners and Decision Makers.
|
|
Contact us at:
(919) 443-6553
|
|
|
|
|
|
|
